专利信息

首页 1 2 3 4 5 下页尾页共 50 条记录, 当前第1/5页。

专利标题：New composition and use

专利权人：SMITHKLINE BEECHAM PLC;

PROBLEM TO BE SOLVED: To provide a therapeutic agent for type II diabetes containing metformin which is a biguanide hypoglycemic drug and 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-24-dione which is an insulin sensitizer inhibiting instability of the agent caused by interaction. SOLUTION: The pharmaceutical composition contains thiazolidinedione dispersed into a pharmaceutically acceptable first carrier and metformin hydrochloride dispersed into a pharmaceutically acceptabl...

专利标题：Novel composition and use

专利权人：SMITHKLINE BEECHAM PLC;

A pharmaceutical composition comprising a thiazolidinedione such as Compound (I) metformin hydrochloride and a pharmaceutically acceptable carrier wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.

专利标题：Farmasoytisk sammensetning og fremgangsmate for fremstilling derav

专利权人：SMITHKLINE BEECHAM PLC;

专利标题：Rosiglitazon maleat og metformin hydroklorid

专利权人：SMITHKLINE BEECHAM PLC;

专利标题：Pharmaceutical composition for modified release of 5-[4-[2-(n- methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and metformin and process for preparing thereof

专利权人：SMITHKLINE BEECHAM PLC;

Pharmaceutical composition suitable for once daily administration which comprises: (a) 2 mg to 12 mg of 5-[4-[2-(N- methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-24-dione i. e. rosiglitazone optionally in the form of a pharmaceutically acceptable salt or solvate thereof; (b) 100 mg to 3000 mg of metformin or a pharmaceutically acceptable salt thereof; and (c) a pharmaceutically acceptable carrier; wherein the composition is arranged to provide sustained release of rosiglitazone and metfor...

专利标题：Pharmaceutical composition and process for the preparation thereof

专利权人：SMITHKLINE BEECHAM PLC;

A pharmaceutical composition comprising a thiazolidinedione metformin hydrochloride and a pharmaceutically acceptable carrier wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier. The invention is also about use of such a composition in medicine.

专利标题：Farmaceutisk sammensætning til modificeret frigivelse af en insulin- sensibilisator og metformin

专利权人：SMITHKLINE BEECHAM PLC;

专利标题：With thiazolidinedione and metformin treatment diabetes

专利权人：SMITHKLINE BEECHAM PLC;

专利标题：Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin

专利权人：SMITHKLINE BEECHAM PLC;

专利标题：Pharmaceutical composition for modified release of an insulin sensitiser and metformin

专利权人：SMITHKLINE BEECHAM PLC;

A pharmaceutical composition which composition comprises: an insulin sensitiser and another antidiabetic agent and a pharmaceutically acceptable carrier therefor wherein the composition is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetes agent and the use of such composition in medicine.

当前查询条件: [专利权人] 包含 'SMITHKLINE BEECHAM PLC' AND [药品] 包含 'Metformin '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. JP2011252007A	2011/12/15	JP20110175883	2011/8/11
专利标题：New composition and use 专利权人：SMITHKLINE BEECHAM PLC; PROBLEM TO BE SOLVED: To provide a therapeutic agent for type II diabetes containing metformin which is a biguanide hypoglycemic drug and 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-24-dione which is an insulin sensitizer inhibiting instability of the agent caused by interaction. SOLUTION: The pharmaceutical composition contains thiazolidinedione dispersed into a pharmaceutically acceptable first carrier and metformin hydrochloride dispersed into a pharmaceutically acceptabl...

2. RS51343B	2011/2/28	RS2002P000388	2000/11/16
专利标题：Novel composition and use 专利权人：SMITHKLINE BEECHAM PLC; A pharmaceutical composition comprising a thiazolidinedione such as Compound (I) metformin hydrochloride and a pharmaceutically acceptable carrier wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.

3. NO329926B1	2011/1/24	NO20020002334	2002/5/15
专利标题：Farmasoytisk sammensetning og fremgangsmate for fremstilling derav 专利权人：SMITHKLINE BEECHAM PLC; A pharmaceutical composition comprising a thiazolidinedione such as Compound (I) metformin hydrochloride and a pharmaceutically acceptable carrier wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.

4. NO2008003I2	2010/6/28	NO20080000003C	2008/4/3
专利标题：Rosiglitazon maleat og metformin hydroklorid 专利权人：SMITHKLINE BEECHAM PLC;

5. SK287038B6	2009/10/7	SK20010000644	1999/11/8
专利标题：Pharmaceutical composition for modified release of 5-[4-[2-(n- methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and metformin and process for preparing thereof 专利权人：SMITHKLINE BEECHAM PLC; Pharmaceutical composition suitable for once daily administration which comprises: (a) 2 mg to 12 mg of 5-[4-[2-(N- methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-24-dione i. e. rosiglitazone optionally in the form of a pharmaceutically acceptable salt or solvate thereof; (b) 100 mg to 3000 mg of metformin or a pharmaceutically acceptable salt thereof; and (c) a pharmaceutically acceptable carrier; wherein the composition is arranged to provide sustained release of rosiglitazone and metfor...

6. SK286985B6	2009/8/6	SK20020067920	2000/11/16
专利标题：Pharmaceutical composition and process for the preparation thereof 专利权人：SMITHKLINE BEECHAM PLC; A pharmaceutical composition comprising a thiazolidinedione metformin hydrochloride and a pharmaceutically acceptable carrier wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier. The invention is also about use of such a composition in medicine.

7. DK1131070T3	2008/11/17	DK19990964483T	1999/11/8
专利标题：Farmaceutisk sammensætning til modificeret frigivelse af en insulin- sensibilisator og metformin 专利权人：SMITHKLINE BEECHAM PLC;

8. CN100431540C	2008/11/12	CN20051116318	1998/6/15
专利标题：With thiazolidinedione and metformin treatment diabetes 专利权人：SMITHKLINE BEECHAM PLC;

9. AT406889T	2008/9/15	AT19990964483T	1999/11/8
专利标题：Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin 专利权人：SMITHKLINE BEECHAM PLC;

10. EP1131070B1	2008/9/3	EP19990964483	1999/11/8
专利标题：Pharmaceutical composition for modified release of an insulin sensitiser and metformin 专利权人：SMITHKLINE BEECHAM PLC; A pharmaceutical composition which composition comprises: an insulin sensitiser and another antidiabetic agent and a pharmaceutically acceptable carrier therefor wherein the composition is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetes agent and the use of such composition in medicine.

下载范围

下载内容